Welcome to our Navigate study

NAVIGATE is a double-blind, Phase 3 study to assess an investigational medication called nizubaglustat for the treatment of Niemann-Pick type C disease and GM1 and GM2 Gangliosidoses.

This guide is to inform patients, family members, and caregivers.